[{"id":"739af689-8f0f-4879-96e4-e964bbd7cece","acronym":"","url":"https://clinicaltrials.gov/study/NCT05947344","created_at":"2023-07-17T14:08:39.121Z","updated_at":"2025-02-25T13:36:25.740Z","phase":"Phase 1","brief_title":"A Study to Evaluate the STI-8591 in Subjects With Advanced Acute Myeloid Leukemia (AML)","source_id_and_acronym":"NCT05947344","lead_sponsor":"Zhejiang ACEA Pharmaceutical Co. Ltd.","biomarkers":" FLT3","pipe":" | ","alterations":" FLT3 mutation","tags":["FLT3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FLT3 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AC0939"],"overall_status":"Recruiting","enrollment":" Enrollment 84","initiation":"Initiation: 12/08/2023","start_date":" 12/08/2023","primary_txt":" Primary completion: 07/01/2025","primary_completion_date":" 07/01/2025","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2024-01-29"}]